Cargando…

Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis

AIMS: In Spain, the first line treatment of hyperphosphatemia in Chronic Kidney Disease (CKD) consists of calcium-based phosphate binders (CB). However, their use is associated with vascular calcification and an increased mortality risk. The aim of this study was to assess the incremental cost-effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gros, Blanca, Galán, Antonio, González-Parra, Emilio, Herrero, Jose A, Echave, Maria, Vegter, Stefan, Tolley, Keith, Oyagüez, Itziar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467815/ https://www.ncbi.nlm.nih.gov/pubmed/26062537 http://dx.doi.org/10.1186/s13561-015-0049-3

Ejemplares similares

Encephalopathy in a dialysis patient treated with lanthanum carbonate (LC)
por: Brancaccio, Diego, et al.
Publicado: (2012)

Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain
por: Rodríguez González-Moro, Jose Miguel, et al.
Publicado: (2015)

Use of Floseal(®), a human gelatine-thrombin matrix sealant, in surgery: a systematic review
por: Echave, María, et al.
Publicado: (2014)

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate
por: Mohammed, Ismail A, et al.
Publicado: (2008)

Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain
por: Mareque, María, et al.
Publicado: (2020)

Encephalopathy caused by lanthanum carbonate
por: Fraile, Pilar, et al.
Publicado: (2011)

Efficacy and safety of lanthanum carbonate on chronic kidney disease–mineral and bone disorder in dialysis patients: a systematic review
por: Zhang, Chenglong, et al.
Publicado: (2013)

Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain
por: Alsina, Laia, et al.
Publicado: (2021)

Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain
por: Navarro, F., et al.
Publicado: (2020)

A confusional state associated with use of lanthanum carbonate in a dialysis patient: a case report
por: Smyth, Michael D. L., et al.
Publicado: (2009)

Lanthanum in Dialysis, the LANDMARK Trial: A #NephJC Editorial
por: Trinidad, Carlo Nemesio B., et al.
Publicado: (2021)

Pharmacology of the Phosphate Binder, Lanthanum Carbonate
por: Damment, Stephen JP
Publicado: (2011)

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone(®)) in Spain
por: Martinez-Raga, Jose, et al.
Publicado: (2012)

The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients
por: Shigematsu, Takashi, et al.
Publicado: (2012)

Gastric lanthanosis (lanthanum deposition) in an immunosuppressed patient that discontinued lanthanum carbonate seven years ago
por: Ullmann, Joana M., et al.
Publicado: (2021)

Cost-effectiveness analysis of timely dialysis referral after renal transplant failure in Spain
por: Villa, Guillermo, et al.
Publicado: (2012)

Lanthanum carbonate hydrate causes artifacts on ultrasound
por: Kuroiwa, Kaori K., et al.
Publicado: (2015)

Diagnosis: Benign bowel distribution of lanthanum carbonate
por: Wu, Hsin-Chi, et al.
Publicado: (2008)

Successful Treatment of Tumoral Calcinosis by Lanthanum Carbonate
por: Hsiao, Ching-Chung, et al.
Publicado: (2018)

Lanthanum Carbonate Opacities—A Systematic Review
por: Kampmann, Jan, et al.
Publicado: (2022)

A Network Meta-Analysis of the Relative Efficacy of Treatments for Actinic Keratosis of the Face or Scalp in Europe
por: Vegter, Stefan, et al.
Publicado: (2014)

The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol
por: Pierce, David, et al.
Publicado: (2011)

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain
por: Mareque, Maria, et al.
Publicado: (2021)

Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain
por: Estrada, Vicente, et al.
Publicado: (2022)

An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis
por: Wasilewska, Anna, et al.
Publicado: (2022)

Quantitative Visualization of Lanthanum Accumulation in Lanthanum Carbonate-Administered Human Stomach Tissues Using Mass Spectrometry Imaging
por: Shimma, Shuichi, et al.
Publicado: (2020)

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients
por: Hutchison, Alastair J, et al.
Publicado: (2013)

Lanthanum carbonate: safety data after 10 years
por: Hutchison, Alastair J, et al.
Publicado: (2016)

The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients
por: Nakamura, Kimihiko, et al.
Publicado: (2019)

Determination of Aluminum in Dialysis Concentrates by Atomic Absorption Spectrometry after Coprecipitation with Lanthanum Phosphate
por: Selvi, Emine Kılıçkaya, et al.
Publicado: (2017)

Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain
por: Ibáñez, R., et al.
Publicado: (2021)

Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease
por: Scaria, P. Thomas, et al.
Publicado: (2009)

Lanthanum associated abnormal liver function tests in two patients on dialysis: a case report
por: Namagondlu, Girish, et al.
Publicado: (2009)

Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2010)

The Risk of Mistaking Intestinal Lanthanum Carbonate for Intestinal Bleeding on CT
por: Salerno, D., et al.
Publicado: (2015)

All that glitters is not gold: A case of lanthanum carbonate aspiration
por: Paranji, Suchitra, et al.
Publicado: (2017)

Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain
por: Calleja, Miguel Angel, et al.
Publicado: (2023)

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
por: Nain, Parminder, et al.
Publicado: (2023)

Healthcare use and costs before and after parathyroidectomy in patients on dialysis
por: Belozeroff, Vasily, et al.
Publicado: (2013)

Visualization of tubular interspaces in the kidney with the aid of lanthanum.
por: Whittembury, G., et al.
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_n77he4ufsjenlfntv9up68af45